PDZ and LIM Domain 4 (PDLIM4) (N-Term) Peptid
PDLIM4
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PDLIM4 Produkte
- PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LRGPSPWGFR LVGGRDFSAP LTISRVHAGS KAALAALCPG DLIQAINGES
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PDLIM4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))
- Hintergrund
-
This gene encodes a protein which may be involved in bone development. Mutations in this gene are associated with susceptibility to osteoporosis.
Alias Symbols: RIL
Protein Size: 330 - Gen-ID
- 8572
- NCBI Accession
- NM_001131027, NP_001124499
- UniProt
- P50479
-
Sie sind hier:
